CompletedNCT01876719
AR08 Compared With Placebo for ADHD in Children
About this title
Read the official source — NCT01876719Researchers compared AR08 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Medication studyAges 6–17United States
Understand this study
What did researchers investigate?
Researchers compared AR08 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
- Listed locations
- Brandenton and 12 more locationsSee all locations and recruitment
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Study information
Study start dateJune 2013
- Recruitment status
- Completed
- Enrollment listed in the registry
- 122
- Sponsor
- Arbor Pharmaceuticals, Inc.
- Sponsor type
- Other organization
- Study type
- Drug
- Intervention type
- Medication / drug
- Study phase
- Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
- Locations
- United States
- Age range
- From 6 Years to 17 Years
- Official registry ID
- NCT01876719
- Official title
Show the full official title
A Randomized, Double-Blind, Placebo-Controlled, Forced Titration, Proof-of-Concept Study of AR08 in the Treatment of Attention Deficit Hyperactivity Disorder in Children (Ages 6 - 17)
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Brandenton · Jacksonville · North Miami
9 more locations
- Orlando
- South Miami
- West Palm Beach
- Atlanta
- Saint Charles
- Las Vegas
- Memphis
- Houston
- Herndon
Questions about this study
What did researchers investigate?
Researchers compared AR08 and placebo to find out how the approaches affected ADHD symptoms in children with ADHD.
Who is behind this study?
The study sponsor is Arbor Pharmaceuticals, Inc.
Did this study involve medication?
Yes. The study involved medication, including AR08 and Placebo.
Who was this study for?
This study was for people with ADHD. Listed age limits: 6 years to 17 years. Other eligibility criteria applied.
